Le Lézard
Classified in: Ebola virus, Health
Subjects: EXE, PSF

Getting Ahead of the Next Pandemic: Is the World Ready?



ATLANTA, Oct. 26, 2017 /PRNewswire-USNewswire/ -- When a deadly mystery illness was detected in Liberia in April 2017, first responders were on the ground within 24 hours. Through the Ministry of Health's quick action and collaboration with global partners, the cause of the outbreak was identified as meningococcal disease and contained with only 31 cases and 13 deaths. In stark contrast, when Ebola struck Liberia just three years ago, it took the country months to mount an effective response; thousands of lives were lost as responders raced to control the growing epidemic.

Centers For Disease Control And Prevention (PRNewsFoto/CDC) (PRNewsFoto/CDC)

The difference between these two outbreaks is just one example of the progress made since 2014 to advance the Global Health Security Agenda's (GHSA) goal to strengthen countries' response capacities. GHSA is a global effort to save lives and reduce the impact of disease threats ? whether naturally occurring or manmade ? by stopping them at their source.

A new article released today in CDC's Emerging Infectious Diseases (EID) journal details early results of CDC's global health security work through collaboration with 17 partner countries. Implementing the Global Health Security Agenda in 17 Countries: Contributions by the Centers for Disease Control and Prevention shows how CDC is accelerating progress toward a world more prepared for public health threats. Part of EID's new Global Health Security Supplement, the article outlines CDC-supported progress during the first two years of GHSA implementation.

With supplemental funding from the U.S. Government of $582 million over five years (FY 2015 ? 2019), CDC is supporting Liberia and 16 other GHSA countries in strengthening core public health systems to rapidly detect, respond, and prevent the spread of disease and limit the impact of outbreaks on families, communities, and whole economies. These efforts include strengthening:

"These core areas are a platform for a functioning public health system in any country and are critical for effective disease detection and response," said Rebecca Bunnell, Ph.D., deputy director for science, policy, and communication in CDC's Division of Global Health Protection and senior author of the article. "From meningococcal disease in Liberia to yellow fever in Uganda, outbreaks can be contained and pandemics prevented when countries have these core capabilities in place."

A timely look at progress toward GHSA milestones

This week, GHSA partner countries, including the United States, meet in Kampala, Uganda, for the 4th High Level GHSA Ministerial Meeting to discuss sustaining and extending these critical efforts. 

"In a world more interconnected than ever ? where emerging diseases continually threaten people's health and drug resistance continues to grow ? ensuring the safety and security of all people requires strong, diverse partnerships and a global commitment to GHSA beyond 2018," said Rebecca Martin, Ph.D., director of CDC's Center for Global Health.

The CDC report describes progress to meet GHSA milestones and concludes that, overall, GHSA partner countries (Phase I) were successful in expanding their capacity for combating public health threats. The analysis found more than 675 advancements across the 17 countries as a result of CDC's GHSA work, including these:

U.S. Department of Health and Human Services

CDC works 24/7 protecting America's health, safety and security. Whether diseases start at home or abroad, are curable or preventable, chronic or acute, or from human activity or deliberate attack, CDC responds to America's most pressing health threats. CDC is headquartered in Atlanta and has experts located throughout the United States and the world.

Contact: CDC Media Relations
(404) 639-3286

 

SOURCE Centers for Disease Control and Prevention (CDC)


These press releases may also interest you

20 sep 2018
Merck , known as MSD outside the United States and Canada, today issued its 2017/2018 global Corporate Responsibility Report. The report reflects the company's performance and progress in its four corporate responsibility priority areas of Access to...

19 sep 2018
The "Heterogeneous Networks (HetNets) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. This report analyzes the worldwide markets for Heterogeneous Networks (HetNets) in US$ Million for major Geographic...

19 sep 2018
The "Dental Infection Control Products - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin...

18 sep 2018
The "Global Anti-infective Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026" report has been added to ResearchAndMarkets.com's offering. The global...

18 sep 2018
Aethlon Medical, Inc. , a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that the National Cancer Institute (NCI) has awarded the Company a government grant (number 1R43CA232977-01). The title...

17 sep 2018
Tru-D SmartUVC, a leader in the UVC disinfection space, will attend and exhibit at the 2018 AHE Exchange, September 23-26 in Columbus, Ohio. Tru-D invites attendees to its booth #623 to learn how the UVC disinfection robot can help prevent...




News published on 26 october 2017 at 16:09 and distributed by: